Healthpeak Properties Appoints Scott Brinker As President, Chief Executive Officer To Replace Tom Herzog
Scott Brinker Appointed President and Chief Executive Officer and Elected as Member of the Board
Tom Herzog Steps Down as Chief Executive Officer and Board Director
Scott Bohn Named Chief Development Officer and Adam
Paramount Programming Executive David Nevins To Leave Company At Year-End
-Wall Street Journal Report
Biden’s CHIPS Act Draws Momentum; IBM Earmarks $20B In Hudson Valley Region Over The Decade
Today U.S. President Joseph R. Biden, Jr. and International Business Machines Corp (NYSE:IBM) Chair and CEO Arvind Krishna will tour…
Costco CFO Said Co. Not Ready to Pass Savings on to Customers as Commodity, Shipping Prices Fall
-Wall Street Journal
https://www.wsj.com/articles/costco-not-ready-to-cut-prices-as-shipping-commodities-costs-fall-11665048601
Assembly Bio Announces Retirement Of John G. McHutchison As CEO And Appoints Current President And COO Jason A. Okazaki As Successor
SOUTH SAN FRANCISCO, Calif., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company developing innovative, investigational therapeutics targeting hepatitis B
Central Valley Community Bancorp Names Interim Chief Financial Officer To Succeed David A. Kinross
James J. Kim, President and CEO of Central Valley Community Bank (CVCB), has appointed Dawn P. Crusinberry, Senior Vice President, Controller, as the Company's Interim Executive Vice President, Chief Financial
Ketamine Therapy At Your Doorstep, Growing Number Of Clinics Offer This Treatment Option
Being the sole psychedelic legally available as medicine, ketamine-assisted therapy services are expanding at a rapid pace across the U.S.
SoftBank Proposes Long-Term Collaboration With Samsung During Seoul Visit: Report
SoftBank Group Corp (OTC:SFTBF) (OTC:SFTBY) founder and CEO Masayoshi Son discussed long-term cooperation between chip designer Arm Ltd and Samsung Electronics Co,…
OncoSec Medical Says Reducing Staff By ~45%, Says Prioritizing Clinical Pipeline Activities To Reduce Operating Expenses
OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec"), a clinical-stage biotechnology company focused on developing intratumoral immunotherapies to stimulate the patient's own